Weight loss therapeutics Market Size, Share, Industry, Forecast and Outlook (2024-2031)

The global weight loss therapeutics market is expected to reach a staggering USD 14,978.1 million by 2030, growing at a CAGR of 24.3% from 2024-2031.

The rising prevalence of chronic diseases like obesity and diabetes, increasing demand for point-of-care treatment, and advancements in therapeutic development are key drivers fueling market expansion.

North America currently dominates the market, holding a 42.3% share in 2022. This is due to the strong presence of major players, rising healthcare expenditure, and increasing awareness about weight management.

Leading players include F Hoffmann-la Roche Ltd, Currax Pharmaceuticals LLC, Viking Therapeutics, Pfizer Inc., and Eli Lilly and Company. These companies are actively involved in research, development, and marketing of weight loss drugs.